Publikasi

Strides partners with Ascent Capital to unlock value in...

Deal values Pivot Path at ~₹2.3 billion post-money; Strides to realise ~₹1 bill...

Alembic Pharmaceuticals gets USFDA approval for Dapsone...

Dapsone Gel is indicated for the topical treatment of acne vulgaris The post Al...

When I took NHS Dentistry to Parliament…

‘NHS dentistry is broken.’ Not my words, but those of the government when it ent...

Treeline’s company event kicked off in Lincoln’s glorio...

Treeline Dental Care has never been a group that stands still, and its first-eve...

Succession and exit planning for private dentists

Adam Thompson explains practice owners can protect and strengthen the value of t...

Major international study on respiratory support in cr...

HN Summary • A major international study led by Scarborough Health Network found...

Helping people breathe easier in a changing climate

HN Summary • In response to the growing challenges from climate change, VCHRI re...

One chord at a time: Ukulele program builds connection ...

HN Summary • Researchers at the Vancouver Coastal Health Research Institute foun...

Gene therapy is changing how we treat disease

HN Summary • Gene therapy is shifting medicine from treating symptoms to targeti...

Global clinical trial reveals safest, most effective a...

HN Summary • An international clinical trial led by researchers including the Re...

Canada should stop the expansion of MAID for mental ill...

What began as a narrowly framed end-of-life exception evolved into a system that...

Supporting teens and young adults living with cancer

Adolescents and young adults (AYA) living with and beyond cancer have unique nee...

Female patients with traumatic brain injury less likely...

Female patients with traumatic brain injury (TBI) are 26% less likely to be admi...

Hantavirus and Ebola virus disease: 10 things to know

Two deadly infectious diseases, Ebola and hantavirus, have made headlines in rec...

To curb overprescribing for seniors, researchers urge ...

To address the growing problem of overprescribing for seniors, a new Canadian gu...

Insilico, SK Launch Up-to-$2.5B Neuroimmune AI Drug Col...

Insilico agreed to apply its Pharma.AI platform, which addresses target validati...